跳至主要内容
临床试验/NCT03021759
NCT03021759已完成不适用

Pragmatic, Randomized Evaluation of Statin Active Choice to Reach Improved Outcomes Based on Evidence

University of Pennsylvania2 个研究点 分布在 1 个国家目标入组 4,774 人开始时间: 2017年2月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
4,774
试验地点
2
主要终点
Statin Prescribing Rate

研究概览

简要总结

In this study, the investigators will conduct a pragmatic, cluster-randomized, controlled trial to evaluate an active choice intervention with and without social comparison feedback to increase physician statin prescribing rates for eligible patients.

详细描述

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States. Strong evidence indicates that statin medications can reduce the risk of CVD and for those with CVD statins have been shown to reduce mortality. Despite this evidence, statins are under-prescribed. In this study, the investigators will test the effectiveness of nudges targeted to physicians using active choice and social comparisons feedback to increasing the rate at which statin medications are prescribed to patients eligible based on national practice guidelines.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Investigator)

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient has a primary care physician at University of Pennsylvania Health System
  • Patient meets 2013 AHA/ACC guidelines for statin therapy but no record of a statin prescription in the electronic health record

排除标准

  • Patient has an allergy or adverse reaction to statins documented in the electronic health record
  • Patient has glomerular filtration rate less than 30 mL/min
  • Physicians (and their respective patients) will be excluded if they have less than 10 patients among their entire panel that are eligible for a statin

研究组 & 干预措施

Control

No Intervention

No intervention

Active choice

Experimental

Physicians will be asked to review a list of their patients eligible for statin therapy who are not yet prescribed a statin and make an active choice whether or not to prescribe a statin.

干预措施: Active choice (Behavioral)

Active choice with social comparison feedback

Experimental

Physicians will be asked to review a list of their patients eligible for statin therapy who are not yet prescribed a statin and make an active choice whether or not to prescribe a statin. Physicians will receive social comparison feedback informing them of how their performance compares to their peers

干预措施: Active choice (Behavioral)

Active choice with social comparison feedback

Experimental

Physicians will be asked to review a list of their patients eligible for statin therapy who are not yet prescribed a statin and make an active choice whether or not to prescribe a statin. Physicians will receive social comparison feedback informing them of how their performance compares to their peers

干预措施: Social comparison feedback (Behavioral)

结局指标

主要结局

Statin Prescribing Rate

时间窗: Two Months

Percentage of patients eligible for a statin that have been prescribed a statin

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验